Familial adenomatous polyposis (FAP) is a hereditary disorder characterized by the formation of numerous adenomatous polyps in the colon and, less commonly, in other organs. This disorder is a serious precancerous condition, as almost all patients with FAP will develop colorectal cancer if preventive measures are not taken. Polyps usually form in adolescence or young adulthood and can lead to the development of negative consequences. FAP is caused by a genetic predisposition, and the main gene involved in this disorder is APCR (adenomatous polyposis syndrome). Treatment of this disorder often requires surgical intervention, as monitoring of polyps and their removal at an early stage is important to prevent carcinogenesis.
History of the disease and interesting historical facts
Familial adenomatous polyposis was first described in the early 20th century, when physicians began to note a link between hereditary predisposition and the development of polyps in the colon. Some of the first mentions of FAP were made by medical researchers such as E. P. K. Lutz, who described a case of polyposis and its association with cancer in 1932. Over the past decades, many genetic studies have been conducted that have allowed us to take into account the genetic nature of this disease and propose strategies for its treatment and monitoring. In general practice, many methods of early diagnosis and treatment have been developed, which has led to a decrease in mortality from colorectal cancer in patients with FAP.
Epidemiology
According to modern research, the prevalence of familial adenomatous polyposis is approximately 1 in 8,000-10,000 people. The disease has a characteristic polygenic predisposition, and its symptoms can appear between the ages of 10 and 40. In some cases, polyposis begins in childhood, which increases the risk of colorectal cancer at a younger age. Statistically, the number of polyps can vary from a dozen to several thousand, which makes this disease especially dangerous. Today, the detection of FAP has become more accessible due to the development of molecular genetic diagnostic methods.
Genetic predisposition to this disease
Familial adenomatous polyposis is caused by mutations in the APC gene, which is located on chromosome 5. This gene encodes a protein responsible for controlling cell growth and preventing tumor formation. A mutation in APCR causes abnormal cell proliferative development, which in turn leads to the formation of polyps in the intestine. In addition to the APC gene, some studies indicate possible associations with other genes, such as MLH1 and MSH2, which further complicates the understanding of the mechanisms of the disease. It is also quite important to note that the probability of inheriting the disease is 50% from a carrier parent.
Risk factors for the development of this disease
Risk factors that contribute to the development of familial adenomatous polyposis can be divided into several categories:
- Genetic: family history of FAP, mutations in the APC gene.
- Environmental: exposure to chemical carcinogens such as nitrogen compounds in the diet or mechanical trauma to the intestine.
- Age-related: The risk of occurrence increases significantly with age, especially after 30 years.
It is worth noting that although heredity is the key factor, behavioral factors such as a sedentary lifestyle, poor nutrition and alcohol abuse can also influence the development of the disease.
Diagnosis of this disease
Diagnosis of familial adenomatous polyposis is based on several key points:
- Main symptoms: the presence of flexible, multiple polyps in the intestines, changes in stool, pain in the abdominal area.
- Laboratory tests: blood tests for markers of inflammation and anemia, genetic testing to detect mutations in the APC gene.
- Radiological examinations: Colonoscopy as the main examination for visualization of polyps, computed tomography for assessment of the condition of the intestine.
- Other types of diagnostics: ultrasound examination, MRI in the presence of complications.
- Differential diagnosis: It is important to distinguish FAP from other types of polyposis, such as Lynch syndrome or sclerosing cholangitis.
An integrated approach to diagnostics ensures more accurate and early detection of the disease, which is certainly important for further treatment.
Treatment
Treatment of familial adenomatous polyposis depends on the severity of the disease and the patient's condition. The main approaches can be divided into the following categories:
- General treatment: includes regular monitoring procedures to detect polyps at early stages.
- Pharmacological treatment: In some cases, medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) are prescribed to reduce the risk of colorectal cancer.
- Surgical treatment: Complete or partial removal of the colon (colonectomy) may be necessary if there are a large number of polyps.
- Other types of treatment: the use of endoscopic methods for removing polyps, which allows avoiding radical operations.
It is important to note that the involvement of a multidisciplinary team of physicians, including gastroenterologists and surgeons, is a key element in the management of this disease.
List of medications used to treat this disease
Currently, the following groups of drugs are used in the treatment of familial adenomatous polyposis:
- Nonsteroidal anti-inflammatory drugs (ibuprofen, aspirin);
- Antioxidants and anticarcinogenic drugs (vitamins E and C);
- Drugs that reduce the risk of cancer (paracetamol);
- Immunotherapeutic agents to support the immune response in cancer.
Optimization of drug therapy requires an individual approach and regular monitoring of the patient's condition.
Disease monitoring
Monitoring the patient's condition with familial adenomatous polyposis is an important stage of treatment. The main control stages include:
- Regular colonoscopies to detect signs of disease progression;
- Early detection of polyps and their annual removal;
- Periodic genetic testing to assess the risk of developing cancer;
- Participate in clinical trials to test new therapies.
The prognosis for patients with successful treatment is quite good, but complications such as colorectal cancer can occur, especially if diagnosis is delayed.
Age-related features of the disease
Familial adenomatous polyposis has specific features depending on the age group:
- In children: manifests as multiple polyps, may be associated with other genetic syndromes.
- In young people: the risk of developing gastrointestinal diseases increases and requires regular monitoring.
- In the elderly: symptoms are more pronounced, complications may lead to the need for surgical intervention.
This age dependence indicates the need for a differentiated approach to monitoring each age group.
Questions and Answers
- What is familial adenomatous polyposis? This is a hereditary disease that causes multiple polyps in the colon and a high risk of colorectal cancer.
- What are the causes of SAP development? The main cause is mutations in the APC gene, which leads to abnormal cell growth.
- What are the symptoms of SAP? The main symptoms include the presence of polyps, abdominal pain, and changes in stool.
- How is the disease diagnosed? Includes genetic testing, colonoscopy, laboratory tests.
- What is the treatment for SAP? Treatment may include observation, drug therapy, and surgical removal of polyps.
Advice from Dr. Oleg Korzhikov
"If you suspect familial adenomatous polyposis, do not delay visiting a doctor. Regular examinations and colonoscopy can save your life. Monitor your health and contact specialists at the first signs of any changes in the body. Questions about your health should always be discussed with medical professionals, without relying on your own guesses and the opinions of friends. In the early stages, the disease responds well to therapy, which gives hope for a positive outcome."
